PARP1 and neoplasm: Treatment with PARPi suppressed the PARP-1/HMGB1 pathway and re-sensitized tumour cells to TRAIL induced cell death suggesting PARPi can sensitize tumours to NK-cell mediated apoptosis (Yang et al., 2015).